SIRIO(SZ:300791) Zheng Quan Zhi Xing·2025-07-18 16:19Core Points - The article outlines the information disclosure deferral and exemption management system of Xianle Health Technology Co., Ltd, ensuring compliance with relevant laws and regulations [1][2][3] - The company is required to implement internal review procedures before determining whether to defer or exempt information disclosure [2][3] - The system emphasizes the importance of confidentiality regarding state secrets and commercial secrets, prohibiting any form of disclosure that could lead to competitive disadvantages or legal violations [3][4][5] Summary by Sections General Principles - The system is established to regulate the deferral and exemption of information disclosure, ensuring compliance with laws such as the Company Law and Securities Law [1] - The company must adhere to the Shenzhen Stock Exchange's rules regarding information disclosure deferral and exemption [1][2] Scope of Deferral and Exemption - The company must prudently assess whether information qualifies for deferral or exemption based on established criteria [2][3] - Evidence must be provided to justify any new deferral or exemption requests post-initial public offering [2][3] Management Procedures - A written application must be submitted to the board office for any deferral or exemption, detailing the reasons and supporting evidence [4][5] - The board office is responsible for reviewing applications and ensuring compliance with the established criteria [5][6] - Confidentiality commitments must be obtained from all individuals aware of the deferred or exempt information [6][7] Additional Provisions - The company must monitor and report on the status of deferred or exempt disclosures, especially if there are rumors or leaks [6][7] - The system is subject to revision and interpretation by the board of directors, and it becomes effective upon board approval [7][8]